Abstract

Metachromatic leucodystrophy (MLD) is a rare inherited lysosomal disorder caused by reduced activity of the enzyme arylsulfatase A with accumulation of sulfatides in the nervous system. We report a female child affected by MLD who developed central precocious puberty (CPP). This association has not been described so far. The proposita, after normal growth and psychomotor development, at age of 30 months presented with a rapidly progressive gait disturbance with frequent falls and with loss of acquired language skills. Magnetic resonance imaging showed leukoencephalopathy. Biochemical blood essays showed a 91% reduction in the arylsulfatase A activity and genetic analysis revealed compound heterozygous mutations of the Arylsulfatase A gene, enabling diagnosis of MLD. Subsequently, the patient had further rapid deterioration of motor and cognitive functions and developed drug-resistant epilepsy. At 4 years and 7 months of age bilateral thelarche occurred. Magnetic resonance imaging showed a small pituitary gland, extensive signal changes of the brain white matter, increased choline, decreased N-acetyl-aspartate and presence of lactate on 1HMR spectroscopy. Pelvic ultrasound demonstrated a slightly augmented uterine longitudinal diameter (42 mm). The gonadotropin-releasing hormone stimulation test revealed a pubertal LH peak of 12.9 UI/l. A diagnosis of CPP was made and treatment with gonadotropin-releasing hormone agonists was initiated, with good response. In conclusion, a CPP may occur in MLD as in other metabolic diseases with white matter involvement. We hypothesize that brain accumulation of sulfatides could have interfered with the complex network regulating with the hypothalamic-pituitary axis and thus triggering CPP in our patient.

Highlights

  • Metachromatic leucodystrophy (MLD; OMIM #250100) is a rare autosomal recessive inherited lysosomal disorder, caused by reduced activity of the enzyme arylsulfatase A, due to mutations in the Arylsulfatase A gene (ARSA; OMIM ∗ 607574) that is located on chromosome 22q13.33 [1, 2]

  • We report the first case of central precocious puberty (CPP) occurrence in a patient affected by MLD

  • Several central nervous system (CNS) diseases including inherited metabolic diseases causing damage to the brain white matter can be associated with CPP or delayed puberty, the pathogenic link between these conditions and CPP is obscure

Read more

Summary

INTRODUCTION

Metachromatic leucodystrophy (MLD; OMIM #250100) is a rare autosomal recessive inherited lysosomal disorder, caused by reduced activity of the enzyme arylsulfatase A, due to mutations in the Arylsulfatase A gene (ARSA; OMIM ∗ 607574) that is located on chromosome 22q13.33 [1, 2]. We report the case of a girl affected by MLD who developed central precocious puberty (CPP). This association has not been described so far. Written informed consent was obtained from the parents of the patient for the publication of this case report This female child was diagnosed with juvenile variant of MLD at 2.5 years of age. She had exhibited normal growth and psychomotor development. After 6 months of therapy, a GnRH stimulation test showed a LH peak concentration of 1.42 IU/l and a reduced value of estradiol (80.03 pmol/L)

Laboratory Methods
Findings
DISCUSSION
CONCLUDING REMARKS
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call